ERT secures new ‘top tier’ ePRO contracts
US-based cardiac and respiratory ePRO specialist, ERT, has secured three new contracts with ‘top tier’ pharmaceutical companies.
Archives for April 17, 2011
Hikma invests in Mumbai-based Unimark Remedies
MENA-focused drug manufacturer, Hikma, has entered into a strategic partnership with Indian API and intermediates business, Unimark Remedies.
ATMI Finesses single-use bioreactors with process control tech deal
ATMI has added process control to its single-use bioreactor through a distribution deal with Finesse Solutions.
Teva withdraws lansoprazole after tube blocking reports
Teva has withdrawn its lansoprazole delayed-release ODT formulation after reports it blocked oral syringes and feeding tubes.
Quintiles backs I-SPY-2 breast cancer trial
Quintiles has leant its support to I-SPY 2, an innovative clinical trial designed to accelerate the development of treatments for breast cancer.
FDA to amend trial investigator disqualification regulations
The FDA is planning to change clinical investigator disqualification regulations following GAO recommendations.